Compare MHD & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MHD | OMCL |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | N/A | 2000 |
| Metric | MHD | OMCL |
|---|---|---|
| Price | $10.99 | $37.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $57.43 |
| AVG Volume (30 Days) | ★ 1.0M | 564.8K |
| Earning Date | 01-01-0001 | 10-29-2026 |
| Dividend Yield | ★ 4.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.01 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $3.69 |
| Revenue Next Year | N/A | $0.92 |
| P/E Ratio | ★ N/A | $39.02 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $9.98 | $31.75 |
| 52 Week High | $12.08 | $51.84 |
| Indicator | MHD | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 63.31 | 54.42 |
| Support Level | $10.67 | $35.57 |
| Resistance Level | $11.84 | $44.35 |
| Average True Range (ATR) | 0.14 | 1.78 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 93.75 | 42.77 |
Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.